Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
7.40
+0.58 (8.50%)
Sep 16, 2025, 3:44 PM EDT - Market open
Tango Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts that cover Tango Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $10, which forecasts a 35.14% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $13.
Price Target: $10 (+35.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tango Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $11 | Buy | Initiates | $11 | +48.65% | Aug 19, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | +35.14% | Aug 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +75.68% | Apr 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 5, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $16 → $8 | Strong Buy | Maintains | $16 → $8 | +8.11% | Nov 11, 2024 |
Financial Forecast
Revenue This Year
50.66M
from 42.07M
Increased by 20.42%
Revenue Next Year
17.51M
from 50.66M
Decreased by -65.45%
EPS This Year
-1.19
from -1.19
EPS Next Year
-1.42
from -1.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 65.5M | 44.2M | |||
| Avg | 50.7M | 17.5M | |||
| Low | 14.6M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 55.7% | -12.8% | |||
| Avg | 20.4% | -65.4% | |||
| Low | -65.2% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.00 | -1.16 | |||
| Avg | -1.19 | -1.42 | |||
| Low | -1.46 | -1.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.